A Case of Lassa Fever: Clinical and Virological Findings
Overview
Authors
Affiliations
Five days after arriving in London from Jos a young Nigerian women developed a severe and prolonged illness that proved to be Lassa fever. Virus was not detected in urine during the first three weeks but then appeared and reached a peak during the sixth week, with continuing excretion for 67 days after the onset of illness. Laboratory investigations showed evidence of extensive tissue damage and disturbance of clotting, but there was no serious bleeding and she eventually made a complete recovery despite a high sustained viraemia and severe liver damage. Convalescent serum was used in treatment but it was difficult to assess its contribution to the favourable outcome.
Cases of high-consequence infectious diseases identified in the UK, 1962-2023.
Atkinson B, Beadsworth M, Dunning J J Med Microbiol. 2025; 74(3).
PMID: 40071494 PMC: 11903645. DOI: 10.1099/jmm.0.001982.
Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus.
Cross R, Fenton K, Woolsey C, Prasad A, Borisevich V, Agans K Cell Rep Med. 2024; 5(2):101392.
PMID: 38280377 PMC: 10897540. DOI: 10.1016/j.xcrm.2024.101392.
Cross R, Heinrich M, Fenton K, Borisevich V, Agans K, Prasad A Proc Natl Acad Sci U S A. 2023; 120(34):e2304876120.
PMID: 37590417 PMC: 10450431. DOI: 10.1073/pnas.2304876120.
Welch S, Genzer S, Coleman-McCray J, Harmon J, Scholte F, Montgomery J Emerg Microbes Infect. 2022; 11(1):1390-1393.
PMID: 35481464 PMC: 9132395. DOI: 10.1080/22221751.2022.2071637.
Merson L, Bourner J, Jalloh S, Erber A, Salam A, Flahault A PLoS Negl Trop Dis. 2021; 15(9):e0009788.
PMID: 34547033 PMC: 8486098. DOI: 10.1371/journal.pntd.0009788.